精神药理学与心理疗法治疗焦虑。

A M Freedman
{"title":"精神药理学与心理疗法治疗焦虑。","authors":"A M Freedman","doi":"10.1055/s-2007-1019646","DOIUrl":null,"url":null,"abstract":"<p><p>The symptom of anxiety, perhaps the most common in all clinical medicine, presents in a variety of forms--psychologic, somatic, behavioral--and often masquerades or is misdiagnosed. Anxiety is a manifestation encountered in a heterogeneous group of syndromes or disorders embracing all of psychiatry. It is necessary to develop the best treatment or combination of treatments appropriate for each case or group of cases. In the treatment of anxiety controlled comparative studies indicate that patients receiving psychotherapy do better than controlled groups. According to present knowledge no one method of psychotherapy is superior to others. The effectiveness of pharmacotherapy alone in the treatment of anxiety is unequivocally established. However, combined therapy of pharmacologic agents and psychotherapy would appear to be superior to either therapy alone. Critical research using existing modalities and combinations of modalities is of vital importance in the treatment of anxiety. Rapid developments in the past twenty-five years in the discovery and differential use of pharmacotherapeutic agents have stimulated renewed interest in the anxiety states and related disorders, as has the emerging body of knowledge regarding possible specific receptor sites in the brain related to anxiety. These developments have heightened interest in research on anxiety with resulting innovations in treatment.</p>","PeriodicalId":76325,"journal":{"name":"Pharmakopsychiatrie, Neuro-Psychopharmakologie","volume":"13 5","pages":"277-89"},"PeriodicalIF":0.0000,"publicationDate":"1980-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2007-1019646","citationCount":"15","resultStr":"{\"title\":\"Psychopharmacology and psychotherapy in the treatment of anxiety.\",\"authors\":\"A M Freedman\",\"doi\":\"10.1055/s-2007-1019646\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The symptom of anxiety, perhaps the most common in all clinical medicine, presents in a variety of forms--psychologic, somatic, behavioral--and often masquerades or is misdiagnosed. Anxiety is a manifestation encountered in a heterogeneous group of syndromes or disorders embracing all of psychiatry. It is necessary to develop the best treatment or combination of treatments appropriate for each case or group of cases. In the treatment of anxiety controlled comparative studies indicate that patients receiving psychotherapy do better than controlled groups. According to present knowledge no one method of psychotherapy is superior to others. The effectiveness of pharmacotherapy alone in the treatment of anxiety is unequivocally established. However, combined therapy of pharmacologic agents and psychotherapy would appear to be superior to either therapy alone. Critical research using existing modalities and combinations of modalities is of vital importance in the treatment of anxiety. Rapid developments in the past twenty-five years in the discovery and differential use of pharmacotherapeutic agents have stimulated renewed interest in the anxiety states and related disorders, as has the emerging body of knowledge regarding possible specific receptor sites in the brain related to anxiety. These developments have heightened interest in research on anxiety with resulting innovations in treatment.</p>\",\"PeriodicalId\":76325,\"journal\":{\"name\":\"Pharmakopsychiatrie, Neuro-Psychopharmakologie\",\"volume\":\"13 5\",\"pages\":\"277-89\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1980-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1055/s-2007-1019646\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmakopsychiatrie, Neuro-Psychopharmakologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-2007-1019646\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmakopsychiatrie, Neuro-Psychopharmakologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-2007-1019646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

摘要

焦虑的症状可能是所有临床医学中最常见的,表现形式多种多样——心理上的、身体上的、行为上的——而且经常伪装或被误诊。焦虑是包括所有精神病学在内的形形色色的综合症或障碍的一种表现。有必要制定适合每个病例或病例组的最佳治疗或治疗组合。在治疗焦虑方面,对照比较研究表明,接受心理治疗的患者比对照组做得更好。根据目前的知识,没有一种心理治疗方法优于其他方法。药物治疗在治疗焦虑方面的有效性是明确确立的。然而,药物和心理治疗的联合治疗似乎优于单独治疗。关键研究使用现有的模式和模式的组合是至关重要的治疗焦虑。在过去的25年里,药物治疗药物的发现和不同用途的快速发展,激发了人们对焦虑状态和相关疾病的新兴趣,以及关于大脑中可能与焦虑相关的特定受体位置的新知识。这些发展提高了人们对焦虑研究的兴趣,并带来了治疗方面的创新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Psychopharmacology and psychotherapy in the treatment of anxiety.

The symptom of anxiety, perhaps the most common in all clinical medicine, presents in a variety of forms--psychologic, somatic, behavioral--and often masquerades or is misdiagnosed. Anxiety is a manifestation encountered in a heterogeneous group of syndromes or disorders embracing all of psychiatry. It is necessary to develop the best treatment or combination of treatments appropriate for each case or group of cases. In the treatment of anxiety controlled comparative studies indicate that patients receiving psychotherapy do better than controlled groups. According to present knowledge no one method of psychotherapy is superior to others. The effectiveness of pharmacotherapy alone in the treatment of anxiety is unequivocally established. However, combined therapy of pharmacologic agents and psychotherapy would appear to be superior to either therapy alone. Critical research using existing modalities and combinations of modalities is of vital importance in the treatment of anxiety. Rapid developments in the past twenty-five years in the discovery and differential use of pharmacotherapeutic agents have stimulated renewed interest in the anxiety states and related disorders, as has the emerging body of knowledge regarding possible specific receptor sites in the brain related to anxiety. These developments have heightened interest in research on anxiety with resulting innovations in treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Psychotropic drugs and pregnancy: a review (author's transl)]. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)]. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics. Guidelines for the clinical evaluation of analgesic drugs. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1